DEA - 'This Is Insanity Someone's Got To Act' Marijuana Researcher Files Fed Lawsuit Against DEA Over 'Unconstitutional Process' | Benzinga
A Rhode Island-based cannabis company, MMJ BioPharma Cultivation Inc., filed a complaint against the Drug Enforcement Administration alleging "an unconstitutional administrative proceeding before a DEA Administrative Law Judge (ALJ). "
Upon discovering that DEA director Anne Milgram "illegally appointed the administrative law Judge Teresa Wallbaum" to hear the case, Megan Sheehan and Associates, lawyers representing MMJ, filed for relief seeking an order to halt these what they called "unconstitutional actions."
Last August, MMJ filed a petition for a writ of mandamus in the U.S. Court of Appeals for the District of Columbia Circuit over a bulk manufacturing application submitted almost six years ago and never processed. MMJ's president and founder Duane Boise previously told Benzinga that the inaction goes directly against the Control Substance Act, negatively impacts MMJ and ignores its effort to help those suffering individuals from Huntington's Disease and Multiple Sclerosis through clinical research.
The DEA’s stance on cannabis and possible rescheduling on the federal level will be one of many important topics discussed by industry experts at the upcoming Benzinga Cannabis Capital Conference next week.
‘This Is Insanity'
In the ...